Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults.
The medical records of 39 patients with Acinetobacter bacteremia identified in the period between 1985 and 1995 were reviewed. In 24 cases (62%) the bacteremia was considered to have been clinically significant. Most of the infections (79%) were nosocomial, and the majority of these were acquired in an intensive care unit. Ten (42%) patients developed septic shock complicating the bacteremia and 13 (54%) died. In most of these cases (85%), Acinetobacter bacteremia was thought to have caused or contributed to death. The following variables were associated with a greater risk of mortality: age > 65 years (OR = 16; p = 0.01); development of septic shock (OR = 22; p = 0.004); and the presence of coagulopathy (OR = 20; p = 0.03).
Poutanen
S M
SM
Department of Microbiology, Sunnybrook Health Science Centre, North York, Ontario, Canada.
Louie
M
M
Simor
A E
AE
D000150:Acinetobacter / Q000187:drug effects; D000151:Acinetobacter Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*; D001778:Blood Coagulation Disorders / Q000150:complications; D003428:Cross Infection / Q000382:microbiology; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012772:Shock, Septic / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality
D000900:Anti-Bacterial Agents